Jefferies Group’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-24,500
Closed -$960K 2269
2018
Q1
$960K Buy
24,500
+17,000
+227% +$623K 0.01% 1213
2017
Q4
$245K Buy
+7,500
New +$260K ﹤0.01% 2111
2017
Q1
Sell
-573,600
Closed -$19M 2278
2016
Q4
$19M Buy
573,600
+560,100
+4,149% +$21.7M 0.11% 172
2016
Q3
$669K Sell
13,500
-11,100
-45% -$578K ﹤0.01% 1481
2016
Q2
$1.36M Buy
+24,600
New +$1.44M 0.01% 1033
2015
Q4
Sell
-27,000
Closed -$1.79M 2235
2015
Q3
$1.79M Buy
27,000
+25,000
+1,250% +$1.92M 0.01% 942
2015
Q2
$157K Buy
+2,000
New +$144K ﹤0.01% 2043

Other funds holding ACHC

Jefferies Group's ACHC Position: Q2 2022 in Review

Jefferies Group sold out of Acadia Healthcare (ACHC) in Q2 2022, closing a stake of 5,311 shares — an estimated $348K sold.

Jefferies Group first reported a position in ACHC in Q4 2013 and held it in 11 quarters. The position peaked at $11.3M in Q4 2016. 285 funds tracked by Wall St. Rank hold ACHC as of Q2 2022.

  • Jefferies Group reported no remaining Acadia Healthcare position as of Q2 2022 after selling out during the quarter.
  • Jefferies Group sold 5,311 Acadia Healthcare shares in Q2 2022, an estimated $348K.
  • Jefferies Group first reported a position in Acadia Healthcare in Q4 2013 and held it in 11 quarters.
  • Jefferies Group's Acadia Healthcare position peaked at $11.3M in Q4 2016.
  • 285 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2022.

Based on Jefferies Group's 13F filing for Q2 2022, filed 15 Aug 2022.